文献速递其他结缔组织病

循环细胞外囊泡上的plexin D1可作为多发性肌炎和皮肌炎的潜在生物标志物

Identification of plexin D1 on circulating extracellular vesicles as a potential biomarker of polymyositis and dermatomyositis.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

本研究通过液相色谱-串联质谱分析血清细胞外囊泡蛋白,发现plexin D1在PM/DM患者囊泡中富集,并开发EV夹心ELISA检测plexin D1+囊泡。结果显示PM/DM患者血清plexin D1+囊泡水平显著高于健康对照及其他疾病对照,且与肌痛/肌无力及醛缩酶、白细胞等指标相关,临床缓解后水平下降。

要点

  • PM/DM患者血清plexin D1+细胞外囊泡水平显著高于健康对照及RA、SLE、DMD/BMD患者。
  • plexin D1+囊泡水平与PM/DM患者肌痛或肌无力表现及醛缩酶、白细胞、中性粒细胞、血小板相关。
  • PM/DM患者治疗后临床缓解时血清plexin D1+囊泡水平显著下降。

核心结论

  • 循环plexin D1+细胞外囊泡水平可作为PM/DM的新型血清生物标志物。

研究设计与样本

  • 对10例PM/DM、23例其他自身免疫病患者及10例健康对照的纯化血清EV进行LC/MS分析。
  • 开发EV夹心ELISA,并在54例PM/DM、24例RA、20例SLE、13例SSc、25例DMD/BMD患者及36例健康对照的血清中评估临床效用。

主要发现

  • LC/MS在血清EV中鉴定出1220种蛋白,plexin D1在PM/DM患者EV中相对健康对照或无PM/DM患者富集。
  • EV夹心ELISA显示PM/DM患者血清plexin D1+EV水平显著高于健康对照及RA、SLE、DMD/BMD患者。
  • 伴有肌痛或肌无力的PM/DM患者血清plexin D1+EV水平更高。
  • PM/DM患者血清plexin D1+EV水平与醛缩酶(rs=0.481)、白细胞(rs=0.381)、中性粒细胞(rs=0.450)和血小板(rs=0.408)显著相关。
  • PM/DM患者治疗后临床缓解时血清plexin D1+EV水平显著下降。

临床怎么用

  • 血清plexin D1+EV检测或可作为PM/DM辅助诊断和疾病活动度评估的潜在血清标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We aimed to identify disease-specific surface proteins on extracellular vesicles (EVs) as novel serum biomarkers of PM/DM. METHODS: We performed liquid chromatography-tandem mass spectrometry (LC/MS) on purified EVs from sera of 10 PM/DM patients, 23 patients with other autoimmune diseases and 10 healthy controls (HCs). We identified membrane proteins preferentially present in EVs of PM/DM patients by bioinformatics and biostatistical analyses. We developed an EV sandwich ELISA for directly detecting serum EVs expressing disease-specific membrane proteins and evaluated their clinical utility using sera from 54 PM/DM, 24 RA, 20 SLE, 13 SSc and 25 Duchenne and Becker types of muscular dystrophy (DMD/BMD) patients and 36 HCs. RESULTS: LC/MS analysis identified 1220 proteins in serum EVs. Of these, plexin D1 was enriched in those from PM/DM patients relative to HCs or patients without PM/DM. Using a specific EV sandwich ELISA, we found that levels of plexin D1+ EVs in serum were significantly greater in PM/DM patients than in HCs or RA, SLE or DMD/BMD patients. Serum levels of plexin D1+ EVs were greater in those PM/DM patients with muscle pain or weakness. Serum levels of plexin D1+ EVs were significantly correlated with levels of aldolase (rs = 0.481), white blood cells (rs = 0.381), neutrophils (rs = 0.450) and platelets (rs = 0.408) in PM/DM patients. Finally, serum levels of plexin D1+ EVs decreased significantly in patients with PM/DM in clinical remission after treatment. CONCLUSION: We identified levels of circulating plexin D1+ EVs as a novel serum biomarker for PM/DM.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Uto K, Ueda K, Okano T, et al. Identification of plexin D1 on circulating extracellular vesicles as a potential biomarker of polymyositis and dermatomyositis. Rheumatology (Oxford). 2022. PMID: 34297034. doi:10.1093/rheumatology/keab588

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。